Penn study provides more insights into cardiovascular side effects of breast cancer d

[News]

A receptor protein that is the target of the breast cancer drug trastuzumab (Herceptin) is needed for proper heart blood-vessel development, reported researchers from the Perelman School of Medicine at the University of Pennsylvania.

More... (http://www.news-medical.net/news/20160714/Penn-study-provides-more-insights-into-cardiovascular-side-effects-of-breast-cancer-drug.aspx)